PATENT CLAIM ANALYSIS

Application Number: 15866924
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "544000"]

Abstract:
The present application relates to compounds and methods for reducing the severity of convulsant activity or epileptic seizures, or for the treatment of chronic or acute pain.

Claim (Index 1):
A method for reducing the severity of convulsant activity, comprising administering to a subject a therapeutically effective amount of a compound represented by the following formula (I): wherein, R 1 =R 2 =CH 3  or R 1 =H and R 2 =aryl, wherein aryl is a compound selected from the group consisting of:\n phenyl, unsubstituted or substituted with one or two compounds selected from the group consisting of CH 3 , OH, OCH 3 , SO 2 CH 3 , SO 2 Ph, F, Cl, CF 3 , CN; \n 1- or 2-naphthyl; \n 2-, 3-, or 4-pyridyl, unsubstituted or substituted with one or two compounds selected from the group consisting of CH 3 , OCH 3 , SO 2 CH 3 , SO 2 Ph, F, Cl, CF 3 , CN; \n 2- or 3-furyl, unsubstituted or substituted with one or two compounds selected from the group consisting of CH 3 , OCH 3 , SO 2 CH 3 , SO 2 Ph, F, Cl, CF 3 , CN; or \n 2- or 3-thienyl, unsubstituted or substituted with one or two compounds selected from the group consisting of CH 3 , OCH 3 , SO 2 CH 3 , SO 2 Ph, F, Cl, CF 3 , CN; \n R 3 =H;\n C(O)R 5 , wherein R 5 =H, CH 3 , C 2 H 5 , CH(CH 3 ) 2 , CHCH 3 CN, or aryl; \n C(O)\u2014O\u2014R 6 , wherein R 6 =pharmaceutically acceptable salts, H, C1 to C6 alkyl (straight chain or branched), CH 2 C 6 H 5 , or CH(CH 2 )n, and wherein n=2-5; \n C(O)NH 2 , C(O)NHR 6  or C(O)NR 7 R 8  wherein R 7  and R 8  independently=C1 to C6 alkyl (straight chain or branched), CH 2 C 6 H 5 , aryl, or R 7  and R 8  together=(CH 2 )n, and wherein n=3-5; \n OH, OCH 3 , or OCH 2 C 6 H 5 ; \n S\u2014CH 3 , S\u2014C 6 H 5 , S(O)CH 3 , S(O)C 6 H 5 , SO 2 CH 3 , or SO 2 O 6 H 5 ; \n NO 2 , NH 2 , NHR 6 , NR 7 R 8 , or pharmaceutically acceptable salts thereof; \n C\u2261C\u2014C(O)CH 3 , C\u2261C\u2014C(O)CH(CH 3 ) 2 , C\u2261C\u2014C(O)C 2 H 5 , C\u2261C\u2014C(O)C 6 H 5 , C\u2261C\u2014C(O)\u2014OH, or pharmaceutically acceptable salts of C\u2261C\u2014C(O)\u2014O \u2212 ; or \n CN; and \n R 4 =one or two compounds selected from the group consisting of H, CH 3 , OH, OCH 3 , SO 2 CH 3 , SO 2 Ph, F, Cl, CF 3 , or CN

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15858183', '15309357', '13216927', '15412667', '12981233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.744487221010119
- 35 USC 102 Novelty (BERT): 0.5260811340407517
- Combined Prediction Score: 0.7226466123131823
- Mean Citation Score: 318.422452
- Max Citation Score: 323.6101700000001
- Similarity Product: 241.5765013590992

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test